Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p

Long Noncoding RNA XIST Promotes Osteosarcoma Progression by Targeting Ras-Related Protein RAP2B via miR-320b

(2018) Gong-Yi Lv et al.   ONCOLOGY RESEARCH

Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis

(2017) Rui Zhang et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR

(2017) Wei Wei et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer

(2017) Min Sun et al.   Journal of Hematology & Oncology

Early Lymphocyte Recovery and Outcome in Osteosarcoma

(2017) Lynn Lee et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma

(2017) Y-H. Zhang et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma

(2016) Corinne Bouvier et al.   Oncotarget

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

(2015) Fa-Xing Yu et al.   CELL

Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma

(2015) Haikang Cai et al.   JOURNAL OF SURGICAL RESEARCH

High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer

(2015) P. C. Schouten et al.   MOLECULAR CANCER THERAPEUTICS

microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling

(2015) CHENG ZHAO et al.   Experimental and Therapeutic Medicine

microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression

(2015) XINJIE DU et al.   Oncology Letters

MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1

(2015) Kang Han et al.   Oncotarget

MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1

(2015) Richa Singh et al.   Scientific Reports

TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR

(2015) Qian Zhang et al.   PLoS One

Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma

(2014) Kjetil Berner et al.   ACTA ONCOLOGICA

The Hippo pathway in chemotherapeutic drug resistance

(2014) Yulei Zhao et al.   INTERNATIONAL JOURNAL OF CANCER

The multilayered complexity of ceRNA crosstalk and competition

(2014) Yvonne Tay et al.   NATURE

The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

(2013) M. A. Salvador et al.   CLINICAL CANCER RESEARCH

Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in Human Embryonic Stem Cell Self-Renewal

(2013) Yue Wang et al.   DEVELOPMENTAL CELL

Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression

(2013) L H Chan et al.   ONCOGENE

A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA

(2011) Marcella Cesana et al.   CELL

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

(2011) Leonardo Salmena et al.   CELL

Molecular Mechanisms of Long Noncoding RNAs

(2011) Kevin C. Wang et al.   MOLECULAR CELL

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Epidemiology of bone tumours in children and young adults

(2009) Rachel Eyre et al.   PEDIATRIC BLOOD & CANCER

Misbehaviour of XIST RNA in Breast Cancer Cells

(2009) Silvia M. Sirchia et al.   PLoS One